Product Code: GVR-1-68038-412-3
Flow Cytometry Market Growth & Trends:
The global flow cytometry market size is expected to reach USD 9.28 billion by 2030, registering a CAGR of 7.07% over the forecast period, according to a new report by Grand View Research, Inc. Technological advancements in the technique are introducing new and improved analytical tools, which include the development of microfluidic flow cytometry for Point-of-Care (PoC) testing. Furthermore, the rising prevalence of cancer, immunodeficiency disorders, and infectious diseases is driving the industry. In addition, increasing R&D investments in biopharmaceutical, life science, and biotechnology research activities have led to high demand for flow cytometry instruments.In recent years, a key focus has been on the development of portable microfluidic flow cytometry devices for PoC testing.
Microfluidics and flow cytometry together make a useful tool to measure multiple characteristics of biological samples. For instance, the easy availability of several microfluidics and miniaturized detectors have enabled the creation of microchip-based cytometers, such as optofluidic cytometer, imaging cytometer, and impedance cytometer. The development of microfluidic flow cytometry devices, which are cost-effective, portable, and compact, is beneficial. They are affordable in developing economies, such as Asia & Africa, and are enabling rapid growth in PoC testing applications.Furthermore, improvements in fluorescent dyes and the increasing utility of benchtop cytometers for academic research settings are expected to drive the industry.
Developments in multicolor flow cytometry are accelerating the adoption of the technique in novel drug development activities. For instance, in January 2020, DxFLEX, CE-IVD, a 13-colour clinical flow cytometry system was launched by Beckman Coulter Life Sciences in Europe. Similarly, easy cellular analysis by simultaneous evaluation of several parameters allows extensive use of such devices for contract research purposes.The COVID-19 pandemic also spurred innovations in the technique, as evidenced by the launch of new products in this domain. For instance, in July 2021, Metropolis Healthcare Ltd. launched CoviRisk-TBNK, a simple blood test to detect the risk status of a COVID-19 hospitalized patient.
It helps analyze patients' need for ICU facilities or ventilation and aids in the reduction of stress on healthcare resources. The test is a flow cytometry-based lymphocyte subset assay and is IVD-approved. Such innovations are anticipated to fuel industry growth in the near future.Moreover, flow cytometry is a significant tool in listing and characterizing immune cells, and is also helpful in recognizing and validating underlying genetic defects. The technique is also used to observe and monitor the immune response of patients after stem cell transplantation, and hence, organ transplantation plays an important role in boosting industry growth. According to the WHO, around 50,000 stem cell transplantations are performed globally every year, and this number is expected to grow in the near future, broadening the scope of applications for the technique.
On the other hand, instruments are highly expensive, and hence, buyers in several developing countries may not be able to afford technologically advanced flow cytometry equipment. These instruments may cost over USD 100,000 and pose significant budgetary constraints for small- & mid-sized hospitals and clinical laboratories. However, some manufacturers, such as Sony, are trying to launch newer instruments using software to automate a number of processes. Such developments would not only improve the usability of the technique but also help bring down the average instrumentation cost-under USD 100,000-in the near future.
Flow Cytometry Market Report Highlights:
- The instrument product segment held the largest share in 2021 due to technical advancements, as well as increased prevalence of chronic conditions
- Thecell-based flow cytometry technology dominated the industry in 2021 due to the high demand for early diagnosis and rising awareness about the associated benefits of cell-based assays
- By application, the clinical segment accounted for the largest revenue share in 2021 owing to increasedR&D activities pertaining to infectious diseases, such as influenza, HIV, and COVID-19, among others
- The academic institutes end-user segment led the market in 2021 owing to increased R&D activities by academic institutes & research centers
- North America was theleadingregion in 2021due to the high implementation of scientifically advanced flow cytometry solutions, high healthcare expenditure, and well-established healthcare infrastructure in the region
- Asia Pacific is expected to register the fastest CAGR from 2022 to 2030 owing to the extensive growth in the pharmaceutical and biotechnology industries in emerging economies, such as China and India
Table of Contents
Chapter 1 Methodology and Scope
- 1.1 Research Methodology
- 1.2 Research Assumptions
- 1.2.1 Estimates And Forecast Timeline
- 1.3 Information Procurement
- 1.3.1 Purchased Database
- 1.3.2 Gvr's Internal Database
- 1.3.3 Secondary Sources
- 1.3.4 Primary Research
- 1.3.5 Details Of Primary Research
- 1.4 Information or Data Analysis
- 1.4.1 Data Analysis Models
- 1.5 Market Formulation & Validation
- 1.6 Model Details
- 1.6.1 Commodity Flow Analysis (Model 1)
- 1.6.1.1 Approach 1: Commodity Flow Approach
- 1.6.2 Volume Price Analysis (Model 2)
- 1.6.2.1 Approach 2: Volume Price Analysis
- 1.7 List Of Secondary Sources
- 1.8 Objectives
- 1.8.1 Objective 1:
- 1.8.2 Objective 2:
- 1.8.3 Market Estimation For Flow Cytometry Market
Chapter 2 Executive Summary
- 2.1 Market Snapshot
- 2.2 Segment Snapshot
- 2.3 Competitive Landscape Snapshot
Chapter 3 Flow Cytometry Market Variables, Trends, & Scope
- 3.1 Market Lineage Outlook
- 3.1.1 Parent Market Outlook
- 3.1.2 Related/Ancillary Market Outlook
- 3.2 Penetration & Growth Prospect Mapping
- 3.2.1 Key Opportunities Prioritized, By Product
- 3.2.2 Key Opportunities Prioritized, By Technology
- 3.2.3 Key Opportunities Prioritized, By Application
- 3.2.4 Key Opportunities Prioritized, By End Use
- 3.3 Market Dynamics
- 3.3.1 Market Driver Analysis
- 3.3.1.1 Growing Prevalence Of Chronic And Infectious Diseases
- 3.3.1.2 High R&D Investments In Biotechnology, Clinical, And Life Science Research
- 3.3.1.3 Technological Advancements In Flow Cytometry Instruments And Reagents
- 3.3.1.4 Increasing Demand For Point-Of-Care Diagnostics
- 3.3.2 Market Restraint Analysis
- 3.3.2.1 High Cost Of Instruments
- 3.3.3 Market Challenges
- 3.3.3.1 Low Cell Throughput Rate
- 3.4 Flow Cytometry: Market Analysis Tools
- 3.4.1 Industry Analysis - Porter's
- 3.4.2 Flow Cytometry - Swot Analysis, By Factor (Political & Legal, Economic And Technological)
- 3.5 Regulatory & Reimbursement Scenario
- 3.6 Pricing Analysis
- 3.7 Trade Data
- 3.7.1 Import/Export Data For Flow Cytometers, By Country
- 3.8 Covid-19 Impact Analysis
Chapter 4 Product Business Analysis
- 4.1 Flow Cytometry Market: Product Movement Analysis, 2021 & 2030
- 4.2 Instruments
- 4.2.1 Global Instruments Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 4.2.2 Cell Analyzers
- 4.2.2.1 Global Cell Analyzers Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 4.2.3 Cell Sorters
- 4.2.3.1 Global Cell Sorters Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 4.3 Reagents & Consumables
- 4.3.1 Global Reagents & Consumables Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 4.4 Software
- 4.4.1 Global Software Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 4.5 Accessories
- 4.5.1 Global Accessories Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 4.6 Services
- 4.6.1 Global Services Market Estimates And Forecasts, 2018 - 2030 (USD Million)
Chapter 5 Technology Business Analysis
- 5.1 Flow Cytometry Market: Technology Movement Analysis, 2021 & 2030
- 5.2 Cell-Based
- 5.2.1 Global Cell-Based Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 5.3 Bead-Based
- 5.3.1 Global Bead-Based Market Estimates And Forecasts, 2018 - 2030 (USD Million)
Chapter 6 Application Business Analysis
- 6.1 Flow Cytometry Market: Application Movement Analysis, 2021 & 2030
- 6.2 Research
- 6.2.1 Global Research Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 6.2.2 Pharmaceutical
- 6.2.2.1 Global Pharmaceutical Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 6.2.2.2 Drug Discovery
- 6.2.2.2.1 Global Drug Discovery Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 6.2.2.3 In Vitro Toxicity
- 6.2.2.3.1 Global In Vitro Toxicity Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 6.2.2.4 Stem Cell
- 6.2.2.4.1 Global Stem Cell Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 6.2.3 Apoptosis
- 6.2.3.1 Global Apoptosis Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 6.2.4 Cell Sorting
- 6.2.4.1 Global Cell Sorting Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 6.2.5 Cell Cycle Analysis
- 6.2.5.1 Global Cell Cycle Analysis Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 6.2.6 Immunology
- 6.2.6.1 Global Immunology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 6.2.7 Cell Viability
- 6.2.7.1 Global Cell Viability Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 6.3 Industrial
- 6.3.1 Global Industrial Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 6.4 Clinical
- 6.4.1 Global Clinical Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 6.4.2 Cancer
- 6.4.2.1 Global Cancer Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 6.4.3 Organ Transplantation
- 6.4.3.1 Global Organ Transplantation Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 6.4.4 Immunodeficiency
- 6.4.4.1 Global Immunodeficiency Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 6.4.5 Hematology
- 6.4.5.1 Global Hematology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
Chapter 7 End Use Business Analysis
- 7.1 Flow Cytometry Market: End-Use Movement Analysis, 2021 & 2030
- 7.2 Commercial Organizations
- 7.2.1 Global Commercial Organizations Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 7.2.2 Biotechnology Companies
- 7.2.2.1 Global Biotechnology Companies Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 7.2.3 Pharmaceutical Companies
- 7.2.3.1 Global Pharmaceutical Companies Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 7.2.4 CROS
- 7.2.4.1 Global CROS Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 7.3 Hospitals
- 7.3.1 Global Hospitals Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 7.4 Academic Institutes
- 7.4.1 Global Academic Institutes Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 7.5 Clinical Testing Labs
- 7.5.1 Global Clinical Testing Labs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
Chapter 8 Regional Business Analysis
- 8.1 Flow Cytometry Market: Regional Movement Analysis
- 8.2 North America
- 8.2.1 North America Market Estimates And Forecast, 2018 - 2030 (USD Million)
- 8.2.2 U.S.
- 8.2.2.1 U.S. Market Estimates And Forecast, 2018 - 2030 (USD Million)
- 8.2.3 Canada
- 8.2.3.1 Canada Market Estimates And Forecast, 2018 - 2030 (USD Million)
- 8.3 Europe
- 8.3.1 Europe Market Estimates And Forecast, 2018 - 2030 (USD Million)
- 8.3.2 Germany
- 8.3.2.1 Germany Market Estimates And Forecast, 2018 - 2030 (USD Million)
- 8.3.3 U.K.
- 8.3.3.1 U.K. Market Estimates And Forecast, 2018 - 2030 (USD Million)
- 8.3.4 France
- 8.3.4.1 France Market Estimates And Forecast, 2018 - 2030 (USD Million)
- 8.3.5 Italy
- 8.3.5.1 Italy Market Estimates And Forecast, 2018 - 2030 (USD Million)
- 8.3.6 Spain
- 8.3.6.1 Spain Market Estimates And Forecast, 2018 - 2030 (USD Million)
- 8.3.7 Russia
- 8.3.7.1 Russia Market Estimates And Forecast, 2018 - 2030 (USD Million)
- 8.4 Asia Pacific
- 8.4.1 Asia Pacific Market Estimates And Forecast, 2018 - 2030 (USD Million)
- 8.4.2 Japan
- 8.4.2.1 Japan Market Estimates And Forecast, 2018 - 2030 (USD Million)
- 8.4.3 China
- 8.4.3.1 China Market Estimates And Forecast, 2018 - 2030 (USD Million)
- 8.4.4 India
- 8.4.4.1 India Market Estimates And Forecast, 2018 - 2030 (USD Million)
- 8.4.5 South Korea
- 8.4.5.1 South Korea Market Estimates And Forecast, 2018 - 2030 (USD Million)
- 8.4.6 Australia
- 8.4.6.1 Australia Market Estimates And Forecast, 2018 - 2030 (USD Million)
- 8.4.7 Singapore
- 8.4.7.1 Singapore Market Estimates And Forecast, 2018 - 2030 (USD Million)
- 8.5 Latin America
- 8.5.1 Latin America Market Estimates And Forecast, 2018 - 2030 (USD Million)
- 8.5.2 Brazil
- 8.5.2.1 Brazil Market Estimates And Forecast, 2018 - 2030 (USD Million)
- 8.5.3 Mexico
- 8.5.3.1 Mexico Market Estimates And Forecast, 2018 - 2030 (USD Million)
- 8.5.4 Argentina
- 8.5.4.1 Argentina Market Estimates And Forecast, 2018 - 2030 (USD Million)
- 8.6 Middle East & Africa
- 8.6.1 Middle East & Africa Market Estimates And Forecast, 2018 - 2030 (USD Million)
- 8.6.2 South Africa
- 8.6.2.1 South Africa Market Estimates And Forecast, 2018 - 2030 (USD Million)
- 8.6.3 Saudi Arabia
- 8.6.3.1 Saudi Arabia Market Estimates And Forecast, 2018 - 2030 (USD Million)
- 8.6.4 UAE
- 8.6.4.1 UAE Market Estimates And Forecast, 2018 - 2030 (USD Million)
Chapter 9 Flow Cytometry Market Competitive Landscape
- 9.1 Recent Developments & Impact Analysis, By Key Market Participants
- 9.2 Company Categorization
- 9.3 Vendor Landscape
- 9.3.1 List Of Key Distributors And Channel Partners
- 9.4 Public Companies
- 9.4.1 Company Market Position Analysis
- 9.4.2 Global Key Company Market Share Analysis, 2021
- 9.5 Private Companies
- 9.5.1 List Of Key Emerging Companies
- 9.5.2 Company Market Position Analysis
- 9.6 Regional Network Map
- 9.7 Company Profiles
- 9.7.1 DANAHER CORPORATION
- 9.7.1.1 Company overview
- 9.7.1.2 Beckman Coulter, Inc.
- 9.7.1.2.1 COMPANY OVERVIEW
- 9.7.1.3 Cytiva
- 9.7.1.3.1 COMPANY OVERVIEW
- 9.7.1.4 Financial performance
- 9.7.1.5 Product benchmarking
- 9.7.1.6 Strategic initiatives
- 9.7.2 BECTON, DICKINSON AND COMPANY (BD)
- 9.7.2.1 Company overview
- 9.7.2.2 Financial performance
- 9.7.2.3 Product benchmarking
- 9.7.2.4 Strategic initiatives
- 9.7.3 SYSMEX CORPORATION
- 9.7.3.1 Company overview
- 9.7.3.2 Financial performance
- 9.7.3.3 Product benchmarking
- 9.7.3.4 Strategic initiatives
- 9.7.4 AGILENT TECHNOLOGIES, INC.
- 9.7.4.1 Company overview
- 9.7.4.2 Financial performance
- 9.7.4.3 Product benchmarking
- 9.7.4.4 Strategic initiatives
- 9.7.5 APOGEE FLOW SYSTEMS LTD.
- 9.7.5.1 Company overview
- 9.7.5.2 Product benchmarking
- 9.7.5.3 Strategic initiatives
- 9.7.6 BIO-RAD LABORATORIES, INC.
- 9.7.6.1 Company overview
- 9.7.6.2 Financial performance
- 9.7.6.3 Product benchmarking
- 9.7.6.4 Strategic initiatives
- 9.7.7 THERMO FISHER SCIENTIFIC, INC.
- 9.7.7.1 Company overview
- 9.7.7.2 Financial performance
- 9.7.7.3 Product benchmarking
- 9.7.7.4 Strategic initiatives
- 9.7.8 STRATEDIGM, INC.
- 9.7.8.1 Company overview
- 9.7.8.2 Product benchmarking
- 9.7.8.3 Strategic initiatives
- 9.7.9 DIASORIN S.P.A.
- 9.7.9.1 Company overview
- 9.7.9.2 Luminex Corporation
- 9.7.9.2.1 COMPANY OVERVIEW
- 9.7.9.3 Financial performance
- 9.7.9.4 Product benchmarking
- 9.7.9.5 Strategic initiatives
- 9.7.10 MILTENYI BIOTEC
- 9.7.10.1 Company overview
- 9.7.10.2 Product benchmarking
- 9.7.10.3 Strategic initiatives
- 9.7.11 SONY BIOTECHNOLOGY, INC.
- 9.7.11.1 Company overview
- 9.7.11.2 Product benchmarking
- 9.7.11.3 Strategic initiatives